Clinical Trial Update: Immunogenicity of Fractional Dose of the HPV Vaccines [Phase 4]

View source ↗

Summary

Clinical trial update in Phase 4 assessing the immunogenicity of fractional-dose HPV vaccines; the study is currently active but not recruiting. The focus is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: University of Washington | Conditions: HPV Infection, HPV Vaccine | Phase 4 | Status: ACTIVE_NOT_RECRUITING